Not available
Quote | AstraZeneca PLC (NYSE:AZN)
Last: | $55.51 |
---|---|
Change Percent: | 2.47% |
Open: | $54.2 |
Close: | $55.51 |
High: | $55.84 |
Low: | $54.02 |
Volume: | 4,954,076 |
Last Trade Date Time: | 09/25/2020 04:55:24 pm |
News | AstraZeneca PLC (NYSE:AZN)
2023-10-02 14:55:14 ET More on Bristol-Myers, Merck, etc. Bristol-Myers: Out Of Favor (Rating Upgrade) Bristol-Myers Squibb: How Cheap Is Cheap Enough? Bristol-Myers Squibb Looks Grossly Overvalued With LOE Taking A Bite Out Of Topline Merck, Bristol Myers, A...
2023-10-01 03:30:00 ET Summary Adlai Nortye completes a $97.5 million IPO on NASDAQ, with its lead drug in a Phase III clinical trial for head and neck squamous cell carcinoma. Nanjing Triastek raises $20 million in a Pre-C financing round to support the development of its 3D prin...
Message Board Posts | AstraZeneca PLC (NYSE:AZN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $AZN News Article - AstraZeneca PLC (NASDAQ: AZN) Records 52-Week High Friday Morning | whytestocks | investorshangout | 04/21/2023 7:30:49 PM |
whytestocks: $AZN News Article - AstraZeneca PLC (NASDAQ: AZN) Records 52-Week High Tuesday Morning | whytestocks | investorshangout | 04/18/2023 7:20:48 PM |
https://twitter.com/Prof_Oak_/status/1646929438594957312 | jondoeuk | investorshub | 04/14/2023 6:02:56 PM |
whytestocks: $AZN News Article - Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Join | whytestocks | investorshangout | 04/12/2023 8:25:49 PM |
whytestocks: $AZN News Article - Astrazeneca Plc (NASDAQ: AZN) Highlighted for Surprising Price Acti | whytestocks | investorshangout | 04/05/2023 6:05:46 PM |
AstraZeneca PLC Company Name:
AZN Stock Symbol:
NYSE Market:
A U.S. District Judge has upheld a pivotal initiative of President Joe Biden, giving the green light for Medicare to commence negotiations on ...
Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeut...
AstraZeneca Plc (NASDAQ: AZN), Bristol Myers Squibb & Co (NYSE: BMY), and Boehringer Ingelheim are willing to particip...